Historische Organisatie
Afrigen Biologics
WHO and South African partners visited Cape Town facilities developing vaccine manufacturing capacity.
Local researchers and manufacturers worked on mRNA technology and transfer to other countries.
The hub aimed to reduce unequal access to vaccine technology exposed during COVID-19.
The visit marked development work, not completion or distribution of a new licensed vaccine.
